P173: Establishing preclinical efficacy for the first AAV gene therapy for GSD IX γ2 across stages of progressive liver disease

• Rebecca Gibson,
• Jeong-A Lim,
• Su Jin Choi,
• Neha Jumani,
• Deeksha Bali,
• Sarah Young,
• William Jeck,
• Baodong Sun,
• Aravind Asokan,
• Priya Kishnani

Affiliations

Rebecca Gibson

Duke University

Jeong-A Lim

Duke University

Su Jin Choi

Duke University

Neha Jumani

Duke University

Deeksha Bali

Duke University

Sarah Young

Duke University

William Jeck

Duke University

Baodong Sun

Duke University

Aravind Asokan

Duke University

Priya Kishnani

Duke University